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A B S T R A C T
Objectives: Our objective was to systematically investigate false-negative histidine-rich protein 2 rapid
diagnostic tests (HRP2-RDT) in imported Plasmodium falciparum malaria cases from travelers to the UK
and the Republic of Ireland (RoI).
Methods: Five imported malaria cases in travellers returning to the UK and RoI from East Africa were
reported to the PHE Malaria Reference Laboratory as negative according to histidine-rich protein (HRP2)-
RDT. The cases were systematically investigated using microscopic, RDT, molecular, genomic, and in in
vitro approaches.
Results: In each case, HRP2-RDT was negative, whereas microscopy confirmed the presence of
P. falciparum. Further analysis revealed that the genes encoding HRP2 and HRP3 were deleted in three of
the five cases. Whole-genome sequencing in one of these isolates confirmed deletions in P. falciparum
chromosomes 8 and 13. Our study produced evidence that the fourth case, which had high parasitemia at
clinical presentation, was a rare example of antigen saturation (‘prozone-like effect’), leading to a false
negative in the HRP2-RDT, while the fifth case was due to low parasitemia.
Conclusions: False-negative HRP2-RDT results with P. falciparum are concerning. Our findings emphasise
the necessity of supporting the interpretation of RDT results with microscopy, in conjunction with clinical
observations, and sets out a systematic approach to identifying parasites carrying pfhrp2 and pfhrp3
deletions.
© 2021 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Introduction
Malaria rapid diagnostic tests (RDTs) are point-of-care immu-
nochromatographic lateral flow assays which detect malaria
antigens in blood from patients with suspected malaria. RDTs
play a key role in the diagnosis and appropriate timely treatment of
malaria throughout malaria-endemic regions (Bruxvoort et al.,
2017). Formats detecting Plasmodium falciparum histidine-rich
proteins (HRP2, HRP3) are the most widely used RDTs in endemic
countries. In non-endemic countries, these are typically used for
initial diagnostic screening and/or to confirm the findings of blood
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(http://creativecommons.org/licenses/by/4.0/).film microscopy, which is considered the gold-standard test. The
availability of reference laboratory confirmatory diagnosis by
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etection of P. falciparum has lower sensitivity than other methods,
nd the false-negative rate resulting from this is exacerbated by
he emergence of P. falciparum parasites that do not express both
RP2 and HRP3 antigens (Berhane et al., 2018; Gamboa et al.,
010). This phenomenon has become a malaria public health
oncern and threatens malaria control and case management
fforts in endemic and non-endemic countries alike (Berhane et al.,
018; Beshir et al., 2017; Gamboa et al., 2010; Grignard et al., 2020;
atson et al., 2017).
P. falciparum parasites that fail to express the histidine-rich
ntigens are known to carry deletions of the pfhrp2 locus on
hromosome 8 (gene ID: PF3D7_0831800) and/or the pfhrp3 locus
n chromosome 13 (gene ID: PF3D7_1372200). Parasites with one
r both loci deleted have been identified in the Americas, Africa,
nd some parts of Asia (Thomson et al., 2020). In Peru and Eritrea,
RP2-based RDTs are no longer deployed due to the high
revalence of HRP-deleted parasites (Berhane et al., 2018; Gamboa
t al., 2010). While the global prevalence of parasites with the
eletion remains low, and appears to be concentrated in certain
opulations, there is a growing recognition by WHO that these
epresent a potential threat to rapid diagnosis of falciparum
alaria, a cornerstone of global control strategies (Gatton et al.,
017; Thomson et al., 2020).
The exact biological function of HRP2 is still unclear, but it has
een linked with hemozoin formation, a process that converts a
oxic, free heme into non-toxic, insoluble hemozoin during
emoglobin digestion (Sullivan et al., 1996). HRP2 has also been
eported to be involved in cytoadherence to endothelial cells of
ostcapillary venules by erythrocytes infected with mature parasite
tages. In a mouse model of P. falciparum infection, HRP2 is reported
o be a virulence factor that may contribute to cerebral malaria (Pal
t al., 2016). It is unknown whether pfhrp2/3 deletion alters parasite
tness or disease severity in vivo. However, the analysis of genetic
rosses between different laboratory strains has not revealed any
eviation of Mendelian expectations for segregation of pfhrp2
eletions in the progeny (Sepulveda et al., 2018).
We have previously identified pfhrp2/pfhrp3-deleted parasites
n malaria cases imported to the UK from Ethiopia, Kenya,
anzania, Somalia, South Sudan, and Sudan (Grignard et al.,
020). In the present study we report clinical, parasitological,
olecular, and genomic details of a series of five P. falciparum-
ositive cases presenting with false-negative HRP2-RDT results in
he UK and the Republic of Ireland (RoI) between 2019 and 2021.
e also report the successful culture adaptation of one pfhrp2/3-
eleted parasite isolate of Sudanese origin.
aterials and methods
etection of malaria parasites in blood samples
Blood samples and fixed blood films from suspected or
onfirmed malaria patients are submitted by laboratories to the
HE Malaria Reference Laboratory (MRL) at the London School of
ygiene and Tropical Medicine (LSHTM) for confirmatory diagno-
is. Films are examined by microscopy, as previously described
Nolder et al., 2013), and molecular analyses performed if
icroscopy is inconclusive and/or if there is any discrepancy
etween MRL and the sending laboratory diagnostic test results.
DTs are not used routinely, and are only deployed (according to
incorrect diagnosis based on RDT findings alone, such as reporting
a non-falciparum malaria infection as the result.
Molecular detection and speciation
Molecular species diagnosis in the MRL combines nested PCR
with species-specific 18S ribosomal gene amplicons identified
using gel electrophoresis (adapted from Calderaro et al., 2007;
Padley et al., 2003; Snounou et al., 1993), and a probe-based qPCR
method that discriminates Plasmodium species (adapted from
Shokoples et al., 2009).
Identification of pfhrp2/pfhrp3 deletion mutants
Where pfhrp2/3 deletions/mutations are suspected by the MRL,
a panel of RDTs that target either pfhrp2/3 or PfLDH antigen are
used to investigate. Available tests include: CarestartTM Malaria
Rapydtest1 (HRP2/pLDH combo Pf/Pan-genus, Apacor); Binax-
NOW Malaria (Pf HRP2/pan-genus aldolase, Alere) and OptiMAL-IT
(Pf LDH/pan-genus LDH, Bio-Rad).
DNA was purified by a robotic DNA extraction system (Qiagen)
following the manufacturer’s instruction, as previously described
(Robinson et al., 2019). Molecular testing for gene deletions was by
assessment of parasite genomic DNA using a multiplex qPCR assay,
as previously described (Grignard et al., 2020). Briefly, the method
uses a multiplex assay targeting pfhrp2 and pfhrp3 as well as
parasite reference and human house-keeping genes. Details of the
genes and components of the qPCR have previously been described
(Beshir et al., 2020; Grignard et al., 2020).
Genomic analysis of pfhrp2 and pfhrp3 loci
To confirm the pfhrp2/3 deletion and determine the extent of
chromosome deletions, whole-genome sequencing (WGS) was
performed using a previously described selected whole genome
amplification (sWGA) method (Ibrahim et al., 2020; Oyola et al.,
2016). The method selectively amplifies parasite DNA using short
oligonucleotide probes of 8–12 mers as primers and enriches
parasite DNA to generate whole-genome sequencing data from low-
parasitemia samples. Detailsof the SWAG method,purification of the
amplified samples, and library preparation of purified samples have
previously been described (Ibrahim et al., 2020). All sequencing
reactions were performed using paired (2) 150 bp reads.
WGS sequence data analysis and adaptation of parasites to in vitro
culture
The methods for whole-genome sequence data analysis and
adaptation of P. falciparum isolates to in vitro culture are detailed in
the supplementary material.
Ethical approval
Ethical approval for the samples from MRL patients was
obtained from the NHS England Research Ethics Committee
(18/LO/0738). Ethical approval for the laboratory work involving
MRL samples was obtained from LSHTM Ethical Review Committee
(#14710).
Results
anufacturer’s instructions) when MRL microscopy results indi-
ate a discrepancy with the sending laboratory’s RDT findings.
Deletions and the presence of genetic polymorphisms located
n pfhrp2 and pfhrp3 are suspected when P. falciparum parasites are
dentified by microscopy or when P. falciparum DNA is confirmed
sing molecular analysis, and the sending laboratory has made an13Patients
Patient 1 (sample S105)
In March 2019, a 72-year-old Sudanese female presented to the
emergency department at a hospital in England with a 1-day8
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recently returned from visiting family in Sudan.
Blood films examined by the sending laboratory suggested
malaria parasites which, following testing by Carestart RDT, were
found to be positive for LDH antigen (pan-genus) only. The sample
was referred to the MRL at LSHTM for confirmation of P. vivax.
Patient 2 (sample S160)
In September 2019, a 17-year-old British male of Somali
heritage presented to the emergency department at a hospital
in London with a 10-day history of symptoms suggestive of
malaria, having returned from a 2-year stay in Uganda the day
before clinical presentation. The patient had started feeling unwell
in Uganda, presented to hospital, and been treated with antibiotics.
He reported not receiving antimalarial treatment because his
malaria diagnostic test was negative.
A provisional diagnosis of P. vivax was made after testing by
Binax RDT, which was found to be positive for aldolase antigen
(pan-genus) only. However, following microscopy, this diagnosis
was revised to severe P. falciparum with > 20% parasitemia, and the
patient was admitted to the intensive care unit, where a course of
appropriate treatment was started. The hospital laboratory
performed a Carestart RDT, which, despite the presence of
microscopy-confirmed P. falciparum hyperparasitemia, generated
only a weak positive signal for PfHRP2, but was positive for pan-
LDH antigen. Blood films and an aliquot of EDTA blood were
referred to the MRL for confirmation of species and investigation of
inconsistency in RDT results. Biochemical data indicated that the
patient had multiple markers of severe malaria (data not shown).
Patient 3 (sample S194)
In January 2020, a 28-year-old male returned to the UK from a
1-week trip to Ethiopia to visit friends and family. He presented to
the emergency department at a hospital in London 3 days after
arrival, reporting a 5-day history of symptoms consistent with
malaria. Scanty trophozoites of P. falciparum were reported despite
a negative result using Binax RDT. The sample was sent to the
Hospital for Tropical Diseases (HTD) in London for confirmation,
because it operates a 24-h out-of-hours malaria diagnosis service.
The sample was initially reported as P. malariae following on-call
microscopy together with a Carestart RDT result negative for the P.
falciparum HRP2/3 antigens, but subsequent examination of the
blood-film by HTD microscopists on the next working day reverted
the previous diagnosis to P. falciparum infection and suspected
false-negative RDT. The sample was sent to the MRL for molecular
confirmation.
Patient 4 (sample S204)
In March 2020, a 55-year-old male returned to the RoI following
a 3-week trip to Sudan, where he had been visiting friends and
family. He reported presenting for medical care in Sudan, with
symptoms suggestive of malaria, 6 days prior to his return to RoI.
Tests for malaria were reported to be negative. The patient then
presented to the emergency department at a hospital in the RoI 3
weeks after arrival, a delay likely to have been caused by the
rapidly emerging SARS-CoV-2 pandemic. Malaria parasites were
seen on blood films and a Carestart RDT was positive for pLDH
(pan-genus) antigen only, indicating a non-falciparum infection.
Samples from the patient were received by the MRL for
confirmation; P. falciparum was diagnosed by microscopy and
confirmed by molecular tests. RDTs were performed, confirming
the sending laboratory’s findings that the sample was negative for
the HRP2/3 antigens. The sample was received within 72 h of being
taken from the patient, and an aliquot was successfully established
in long-term culture, designated as the parasite line HL2004.
Patient 5 (sample S227)
In January 2021, a 51-year-old female returned to the UK from
6-week stay in Zambia where she has been visiting family. The
patient presented to a hospital in England in February and was
diagnosed microscopically with malaria, species unknown, with
scant parasites seen. A Carestart RDT was negative. Slides and an
EDTA blood sample were sent to the MRL for confirmation and
species diagnosis.
P. falciparum was diagnosed in the MRL by microscopy: early
and late trophozoites with Maurer’s clefts were seen. The sample
was tested with Carestart, OptiMAL, and Binax RDTs and all three
were negative for Plasmodium antigens, while AlethiaTM Malaria
LAMP (Meridian Bioscience) was positive. The qPCR indicated that
the infection below 200 p/mL. An aliquot was successfully
established in long-term culture, designated as the parasite line
HL2005.
Diagnostic test results
Diagnostic test results and investigations for the five blood
samples are summarized in Tables 1 and 2. In each case, despite all
five infections being confirmed as P. falciparum, inconsistencies in
RDT results reported by the sending laboratory were also found by
the MRL. These included weak or negative results obtained for
HRP2/3 antigens detection by Carestart or Binax test kits, despite
positive results for the optimal PfLDH antigen. We therefore
suspected possible deletions of the respective genes in all five
cases, and proceeded to assess the genomic status at both the
pfhrp2 and pfhrp3 loci using multiplex qPCR.
Confirmation of pfhrp2/3 deletion using multiplex qPCR
Our one-step quadruplex qPCR assay amplifies three parasite
genes (pfhrp2, pfhrp3, and pfldh) and a human gene (HumTuBB) in a
single reaction. All samples with suspected pfhrp2/3 deletions
showed good amplification of the pfldh target gene (Figure 1),
confirming the presence of good-quality parasite DNA in all
samples. Three samples (S105, S160, and S204) were negative for
Table 1
Summary of investigations for blood samples from five malaria patients referred to the MRL following inconsistent RDT results.












S105 Sudan NEG NEG POS POS POS POS
S160 Uganda WEAK NEG/WEAK POS POS POS POS
S194 Ethiopia NEG NEG POS POS POS POS
S204 Sudan NEG NEG POS POS POS POS
S227 Zambia NEG NEG NEG NEG NEG NEG
Pf: P. falciparum-specific.
LDH: parasite lactate dehydrogenase detectable by specific monoclonal antibodies (MAb) in the RDT.
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ignal in both gene channels. Surprisingly, two samples (S160 and
227) showed amplification signals with Ct values of 22.0 and 28.6,
espectively, for each of the genes, confirming the presence of both
fhrp2 and pfhrp3 (Figure 1, second row). The presence of
mplification signals for both the parasite and human internal
ontrol genes indicated successful DNA extraction and PCR
mplification in each case, and positive controls showed the
xpected amplification signal for all targets. The successfully
ulture-adapted samples (S204 and s227) were investigated for
aintenance of the pfhrp2/3 deletion during the in vitro culture
daptation as isolates HL2004 and HL2005. Molecular analysis of
he DNA extracted from HL2004 at days 21 and 28 following
culture adaptation revealed that the sample generated no
amplification signal for the pfhrp2/3 genes (Figure 2), while the
HL2005 sample produced a good signal. The reference parasite
gene (pfldh) produced a good amplification signal for both samples
(data not shown). This confirmed that both culture-adapted
isolates reflected the results seen in the original patient isolate
(Figure 1, row 4).
Further investigations for S160
Given that qPCR analysis of the parasite DNA from S160
confirmed the presence of intact genes coding for both HRP
antigens, sample dilution was performed to test the hypothesis
able 2
icroscopy, qPCR and parasite culture results for blood samples from five malaria patients referred to the MRL.
Sample reference Travel history Initial diagnosis Microscopy P. falciparum DNA detected? Culture established?
S105 Sudan P. vivax P. falciparum trophozoites
P  0.02%
P. falciparum DNA detected
Ct 20.08
No
S160 Uganda P. vivax/P. falciparum P. falciparum trophozoites
P  24.3%
Not done No
S194 Ethiopia P. falciparum/P. malariae No films received P. falciparum DNA detected
Ct 24.71
No
S204 Sudan Malaria parasites seen; unspecified P. falciparum, all stages
P  0.1%
P. falciparum DNA detected
Ct 22.88
Yes (HL2004)
S227 Zambia Malaria parasites seen; unspecified P. falciparum, late trophozoites
P  0.02%
P. falciparum DNA detected
Ct 25.32
Yes (HL2005)
t: cycle threshold — amplification cycle at which threshold for positivity is crossed by fluorescent signal in qPCR assays. Mean Ct values are given for two replicates.igure 1. Amplification curves for four different genes in five samples. Three samples (S105, S194, and S204) showed no amplification curves for pfhrp2 and pfhrp3 genes,
hile two samples (S160 and S227) showed amplification curves for both pfhrp2 and pfhrp3 genes. All samples showed good amplification curves for both parasite (pfldh) and
uman (humTuBB) internal controls. As expected, all the controls (Dd2, INT, 3BD5, and HB3) showed amplification curves or no amplification curves according to their pfhrp2/
 status.
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accounted for the inconsistent RDT results for HRP antigen
detection in this sample. The undiluted blood sample gave
inconsistent results with HRP RDT, with a weak positive signal
by CarestartTM Malaria Rapydtest1 and a negative result by Binax-
NOW. The original EDTA sample was diluted 1:10 in uninfected
human blood. This dilution tested positive with both RDT formats,
confirming the presence of both PfLDH and PfHRP antigens (data
not shown).
Genomic analysis of pfhrp2 and pfhrp3 loci and P. falciparum isolate
culture
Results for genomic analysis of pfhrp2/3 loci (inculding anlysis
about Figure 3) and adaptation of P. falciparum isolates are
presented in the Supplementary material.
Discussion
This study presents a systematic investigation of false-negative
HRP2-RDT results in travelers to the UK and RoI with imported
malaria due to P. falciparum infection. Clinical, molecular, genomic,
and in vitro evidence is provided, confirming the deletion of pfhrp2/
3 genes in parasites from three patients with false-negative results
by HRP2-RDT. This is the first study to show pfhrp2/3 deletion in
patient samples from UK travelers causing false-negative HRP2-
RDT results. The study also presents evidence that a false-negative
RDT result obtained for a fourth patient was due to a prozone-like
effect due to antigen saturation caused by high parasitemia, and for
a fifth patient due to low parasitemia.
We have previously identified pfhrp2/3 deletions in a molecular
survey of P. falciparum parasites imported into the UK (Grignard
et al., 2020), but these were not linked to diagnostic test failure. In
this study, we show the potentially serious impact of imported
parasites with HRP deletions on RDT performance in the UK and
RoI. With the increase in frequency of such P. falciparum parasites
in endemic countries, over-reliance on HRP2-RDT diagnosis in the
UK or RoI may delay treatment for sick individuals, with life-
threatening consequences. One patient in our series with false-
negative RDT results was admitted to intensive care unit with
hyperparasitemia; he reported receiving no antimalarial treatment
in Uganda prior to travel due to a negative malaria test. Early
presentation, rapid diagnosis, and immediate treatment can
together greatly reduce severe malaria risk, and are the basis of
effective malaria management in non-endemic countries (Check-
ley et al., 2012).
The prozone effect due to high parasitemia has been previously
demonstrated in laboratory studies of both clinical isolates andFigure 2. CarestartTM Malaria Rapydtest1 detection of LDH but not HRP antigens in six independent culture wells 4 weeks after commencing in vitro propagation
of P. falciparum isolate S204. The upper panel shows four representative Giemsa-stained microscopy fields after magnetic purification, which selectively enriches for late-
stage asexual parasites and gametocytes. The lower panel shows readouts from neat culture supernatants from six different culture wells. Following successful
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usceptibility between RDT products was observed, reflecting
ither the quality of the RDT manufacture or the high specificity of
ommercially produced proprietary monoclonal antibodies used
n the test devices. Other researchers have reported prozone-like
ffects at parasitemia leves of 5.5–35% (Gillet et al., 2009), and
here is evidence that high concentrations of patient antibodies
gainst HRP2/3 antigens may also contribute to the inhibition of
DT recognition of antigens (Ho et al., 2014). Thus pfhrp2/3
eletion is not the only factor that contributes to false HRP2-RDT
egative results, and both factors should be considered when faced
ith HRP2-RDT negative results in patients with suspected
alaria. Our findings also emphasize the need for ruling out
ow parasitemia as a possible factor for false-negative RDT results,
s extensively demonstrated in our previous report (Beshir et al.,
017).
For the present study, a multiplex qPCR assay — recently
alidated as a one-step genotyping method (Grignard et al., 2020)
— was used to demonstrate that false-negative RDT results were
caused by the deletion of pfhrp2/3 in three patients. Our results
confirmed that pfhrp2/3-deleted parasites are in circulation in
Ethiopia and Sudan, as previously reported (Boush et al., 2020;
Girma et al., 2019; Golassa et al., 2020; Mussa et al., 2019).
Interestingly, a mathematical modelling exercise (Watson et al.,
2017) predicted the insurgence of such parasites in African
countries with low endemicity, such as Sudan, Somalia, or Ethiopia,
which were the travel origins of the patients we analysed.
However, it is unclear how extensively these parasites circulate
in these countries. At the genomic level, the S105 clinical sample
from Sudan exhibited zero sequence coverage at the pfhrp2 and
pfhrp3 loci, confirming deletion of the two genes and flanking
regions. The deletion of a large proportion of loci surrounding
pfhrp2 and pfhrp3 is similar to the regional loss observed in
laboratory lines Dd2 and HB3 (Sepulveda et al., 2018), though the
loss in Dd2 is smaller (14 kb) compared with the clinical sample
described here (50 kb). The implication of the loss of genesigure 3. Genomic coverage of pfhrp2, pfhrp3, and flanking regions for two clinical samples. Short-read sequence coverage is missing around the pfhrp2 and pfhrp3 in sample
105 (top panel) but not in sample S160 (bottom panel). (A) pfhrp2 and pfhrp3 (dark orange) in clinical sample S105 (top panel) are deleted together with flanking regions that
clude PHIST, STEVOR, EBL1, RIFIN, PHISTb, and HSP70x (purple) but not PfEMP1 and CLAG8 (green). (B) Both pfhrp2 and pfhrp3, as well as the adjacent genes (colored), show
ood genomic coverage in clinical sample S160 (bottom panel).
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that the S160 patient had signs and symptoms attributable to
severe malaria, and it is not clear whether the presence of HRP2
and flanking regions contributed to the severity (Pal et al., 2016) or
it was simply caused by high parasitemia (Kingston et al., 2017).
Cytoadherence — a characteristic of cerebral malaria — is thought
to be mediated by parasite proteins such as RIFINs, STEVORs,
HSP70x, and pfEMP1 (Sherman et al., 2003), all of which are
located in the vicinity of the pfhrp2 or pfhrp3 loci. Whether the loss
of pfhrp2/3 or the flanking regions has any role in parasite fitness or
virulence requires thorough investigation in future studies,
including precision mapping of chromosome breakpoints in
multiple parasites carrying HRP gene deletions.
Attempts to culture-adapt the clinical isolates was successful
for one from a traveller returning to the RoI from Sudan, which
lacked both HRP genes, and one from a UK traveller returning from
Zambia, which harboured both genes. The growth of HRP-negative
parasite line HL2004 was poor compared with other patient-
derived lines with intact pfhrp2/3 previously cultured in our
laboratory (van Schalkwyk et al., 2013). It is not clear whether poor
growth was due to a loss of fitness associated with the deletion of
pfhrp2/3, the delay in establishing the culture, or any other
technical factors. Disruption of pfhrp2 in the 3D7 laboratory line
has been reported to have no effect on parasite growth (Yang et al.,
2020); however, the pfhrp2 locus alone was disrupted by gene
replacement in this study, and so any fitness impact due to loss of
flanking genes was not examined. The exact biological function of
HRP2 is still unclear, but it has been linked with hemozoin
formation in several studies (Schneider and Marletta, 2005;
Sullivan et al., 1996). The pfhrp2 knock-out 3D7 parasite line has
been shown to transcriptionally downregulate enzymes required
for heme metabolism in the food vacuole, but to upregulate
transcripts for proteins required for heme biosynthesis in the
apicoplast, potentially maintaining a relatively unchanged heme
level in the parasite (Yang et al., 2020). This might indicate that
pfhrp2 deletion can impact parasite survival in the mosquito and
liver stages, as de novo heme biosynthesis in the apicoplast has
been reported to be essential in the mosquito (Ke et al., 2014) and
liver stages (Nagaraj et al., 2013). Clonal expansion of pfhrp2-
deleted parasites has been observed in Eritrea and Ethiopia
(Berhane et al., 2018; Girma et al., 2019; Golassa et al., 2020), but it
remains unclear whether the parasites with pfhrp2 deletion have a
fitness advantage or deficit compared with the wild type. In areas
where RDT-testing and treatment is a policy, the pfhrp2-deleted
parasites would evade HRP2-RDT detection and would therefore
not be exposed to antimalarial onslaught. This potentially gives
pfhrp2-deleted parasites survival and expansion advantages over
the wild type (Watson et al., 2017). Mosquito transmission studies
are now needed to understand the role of pfhrp2/3 and flanking
regions in the expansion of pfhrp2/3-deleted parasite populations
in malaria-endemic countries. The gametocyte-producing proper-
ty of HL2004 suggests that this isolate is ideal for such a study.
Our study had some limitations, including the small number of
clinical samples in which the impact of pfhrp2/3 deletion on RDT
performance in the UK and RoI was evaluated. Similarly, the precise
role of high parasitemia on HRP2-RDT performance, which
dramatically affected diagnostic results for one patient reported
here, requires assessment in a larger patient series. Finally, the
culture-adapted HRP-negative isolate will undoubtedly prove a
useful research tool as well as a potential source of reference
Our investigations enhance the existing evidence base, and
support the continued use of RDT as a rapid and convenient
screening tool for imported malaria, but one that should only be
deployed when backed-up by high-quality microscopy and
capacity for DNA-based molecular tests. Although RDT diagnostic
failures remain rare among imported UK malaria cases, molecular
surveillance of pfhrp2/3 needs to be maintained so that the impact
of imported P. falciparum with pfhrp2/3 deletion on RDT perfor-
mance in the UK can be continuously monitored.
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